Literature DB >> 17309387

Broken needle in the cervical spine: a previously unreported complication of Xiaozendao acupuncture therapy.

Jiin-Tarng Liou1, Fu-Chao Liu, Shi-Tai Hsin, Daniel Ching-Wah Sum, Ping-Wing Lui.   

Abstract

Xiaozendao (meaning "small-needle-knife," in Chinese) is a form of alternative medical instrument shaped like an acupuncture needle with a flat edge on the needle tip. It is widely used for the treatment of many different disorders in Asian countries, especially in the People's Republic of China. Its use has gained increasing popularity. To our knowledge, there are no reports of practitioners' experiences or adverse events related to "small-needle-knifed" therapy until now. We reported the first case of spinal-cord injury with delayed onset of neurologic symptoms from a broken small-needle-knife insertion into the spinal cord.

Entities:  

Mesh:

Year:  2007        PMID: 17309387     DOI: 10.1089/acm.2006.6007

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  3 in total

1.  Miniscalpel-Needle versus Steroid Injection for Plantar Fasciitis: A Randomized Controlled Trial with a 12-Month Follow-Up.

Authors:  Shuming Li; Tong Shen; Yongshan Liang; Ying Zhang; Bo Bai
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-08       Impact factor: 2.629

2.  Development of a survey form through Delphi study about adverse events associated with the miniscalpel needle, for application in prospective observational studies regarding safety of miniscalpel needles: Study protocol.

Authors:  Sang-Hoon Yoon; Haebeom Lee; Chan-Young Kwon; Damin Jeon; Hyunho Kim; Hee-Geun Jo; Aesook Shin; Younghee Yun; Jae-Uk Sul; Geon-Mok Lee; Jun-Hwan Lee; Jungtae Leem
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

3.  Adverse events of acupuncture: a systematic review of case reports.

Authors:  Shifen Xu; Lizhen Wang; Emily Cooper; Ming Zhang; Eric Manheimer; Brian Berman; Xueyong Shen; Lixing Lao
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.